Vivian S. Lee

President, Health Platforms - Verily Life Sciences

Dr. Vivian Lee is President of Health Platforms at Verily Life Sciences whose mission is to apply digital solutions that enable people to enjoy healthier lives. Elected to the National Academy of Medicine with 200 peer-reviewed publications, Lee’s NIH-funded laboratory has developed acclaimed methods for diagnosis and detection using MRI. She is a top healthcare executive, lecturer and author and is widely recognized as one of the most influential people in modern healthcare.

Molly Shoichet

Principal Investigator -IBBME, University of Toronto

Dr. Molly Shoichet holds the Tier 1 Canada Research Chair in Tissue Engineering at the University of Toronto. She served as Ontario’s first Chief Scientist in 2018 and currently leads a laboratory focused on drug and cell delivery in the central nervous system, and 3D hydrogel culture systems to model cancer. Dr. Shoichet has since co-founded four spin-off companies and is the only person to be inducted into all three of Canada’s National Academies of Science, Engineering and Health Sciences.

Dena Shahriari

Postdoctoral Researcher -Massachusetts Institute of Technology

Dr. Dena Shahriari is a Postdoctoral Fellow at the Bioelectronics Laboratory at Massachusetts Institute of Technology, and is an incoming Assistant Professor at the University of British Columbia and the International Collaboration on Repair Discoveries (ICORD). Dr. Shahriari’s work resulted in a technique to bridge nerve gaps, and led to development of neural probes to study effects of nerve repair using optical stimulation. She aims to find a cure for traumatic nerve injury and paralysis.

Fiona Brinkman

Principal Investigator -Simon Fraser University

Dr. Fiona Brinkman is a Distinguished Professor at Simon Fraser University, and is a renowned leader in bioinformatics. Her lab focuses on bioinformatics aids for integrative analyses of microbe and genomics data. She co-leads IRIDA.ca, a primary platform in the Public Health Agency of Canada to study disease outbreaks with genomic epidemiology. She is a member of the Implementation Committee for the Canadian COVID-19 Genomics Network (CanCOGeN) and was inducted into the Royal Society of Canada.

Pawan Jolly

Senior Staff Scientist-

Wyss Institute, Harvard University

Dr. Pawan Jolly is a Senior Staff Scientist at the Wyss Institute for Biologically Inspired Engineering at Harvard University. His expertise lies in surface biochemistry, analytical assay development, DNA and protein-based biosensors and electrochemical sensors, specifically in the field of medical devices and diagnostics. He was recently awarded the 2020 Young Chemist Award for his novel multiplexed, portable, electrochemical sensor (eRapid) and its use in biomarker detection.

Dr. Kristen Fortney is CEO and co-founder of BioAge Labs, a revolutionary anti-aging startup coupling genomics and machine learning to develop a pipeline of therapies that increase healthspan. She received her PhD in Medical Biophysics from the University of Toronto, followed by postdoctoral training at Stanford University. She has over 10 years of success in developing novel data science and AI approaches spanning drug discovery, biomarkers and genetics of exceptional human longevity.

Kristen Fortney

Co-Founder & CEO - BIOAGE

Nadeem Sarwar is Founder and President of the Eisai Center for Genetics Guided Dementia Discovery, with experience in academia (Tenured Faculty, University of Cambridge), big-pharma (Senior Director, Pfizer) and biotechnology. He sits on the US National Academies of Sciences Roundtable on Genomics & Precision Health and leads the Precision Therapeutics group. Nadeem’s expertise stems from the intersection of genomics and data sciences with collaborative business models for therapeutic discovery.

Nadeem Sarwar

Founder and President - Eisai Center for Genetics Guided Dementia Discovery